Uppsala, Sweden

Martin Kjell Lindberg


Average Co-Inventor Count = 4.4

ph-index = 3

Forward Citations = 22(Granted Patents)


Location History:

  • Uppsala, SE (1998 - 1999)
  • 57 Uppsala, SE (2000)
  • 07 Uppsala, SE (2004)

Company Filing History:


Years Active: 1998-2004

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Martin Kjell Lindberg: Innovator in Biotechnology

Introduction

Martin Kjell Lindberg is a notable inventor based in Uppsala, Sweden. He has made significant contributions to the field of biotechnology, particularly in the development of proteins with therapeutic and diagnostic applications. With a total of 4 patents, Lindberg's work has the potential to impact medical diagnostics and treatment.

Latest Patents

Lindberg's latest patents include a fibrinogen binding protein originating from coagulase-negative staphylococcus. This invention encompasses a new fibrinogen binding protein or polypeptide derived from coagulase-negative staphylococci, along with biotechnological methods for producing the protein or polypeptide that exhibits fibrinogen binding activity. Additionally, it includes a recombinant DNA molecule coding for the protein or its fragments, as well as micro-organisms, including viruses, that contain this recombinant DNA molecule. The invention also covers the therapeutic and diagnostic use of the protein and/or DNA, such as a diagnostic kit for determining the presence and/or type of coagulase-negative staphylococci and a vaccine composition comprising the protein or DNA. Another patent involves DNA encoding the alpha-2-macroglobulin binding protein and the protein encoded thereby.

Career Highlights

Throughout his career, Martin Kjell Lindberg has worked with various organizations, including Pharmacia Biotech Aktiebolag. His innovative work has positioned him as a key figure in the biotechnology sector, contributing to advancements that may enhance medical practices.

Collaborations

Lindberg has collaborated with notable individuals in his field, including Bengt Mikael Guss and Jan Ingmar Flock. These partnerships have likely fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Martin Kjell Lindberg's contributions to biotechnology through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical diagnostics and therapeutics.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…